Correlation Between CTi Biopharma and X4 Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CTi Biopharma and X4 Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CTi Biopharma and X4 Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CTi Biopharma Corp and X4 Pharmaceuticals, you can compare the effects of market volatilities on CTi Biopharma and X4 Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CTi Biopharma with a short position of X4 Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of CTi Biopharma and X4 Pharmaceuticals.

Diversification Opportunities for CTi Biopharma and X4 Pharmaceuticals

-0.77
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between CTi and XFOR is -0.77. Overlapping area represents the amount of risk that can be diversified away by holding CTi Biopharma Corp and X4 Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on X4 Pharmaceuticals and CTi Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CTi Biopharma Corp are associated (or correlated) with X4 Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of X4 Pharmaceuticals has no effect on the direction of CTi Biopharma i.e., CTi Biopharma and X4 Pharmaceuticals go up and down completely randomly.

Pair Corralation between CTi Biopharma and X4 Pharmaceuticals

Given the investment horizon of 90 days CTi Biopharma Corp is expected to generate 1.14 times more return on investment than X4 Pharmaceuticals. However, CTi Biopharma is 1.14 times more volatile than X4 Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. X4 Pharmaceuticals is currently generating about 0.01 per unit of risk. If you would invest  564.00  in CTi Biopharma Corp on August 29, 2024 and sell it today you would earn a total of  345.00  from holding CTi Biopharma Corp or generate 61.17% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy27.68%
ValuesDaily Returns

CTi Biopharma Corp  vs.  X4 Pharmaceuticals

 Performance 
       Timeline  
CTi Biopharma Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CTi Biopharma Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound forward indicators, CTi Biopharma is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
X4 Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days X4 Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

CTi Biopharma and X4 Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CTi Biopharma and X4 Pharmaceuticals

The main advantage of trading using opposite CTi Biopharma and X4 Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CTi Biopharma position performs unexpectedly, X4 Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in X4 Pharmaceuticals will offset losses from the drop in X4 Pharmaceuticals' long position.
The idea behind CTi Biopharma Corp and X4 Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
CEOs Directory
Screen CEOs from public companies around the world
Money Managers
Screen money managers from public funds and ETFs managed around the world
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments